Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
about
Oral morphine for cancer painOral morphine for cancer painOral morphine for cancer painStrong opioids for cancer painThe role of morphine glucuronides in cancer pain.Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes.Oral-parenteral conversion factor for morphine in palliative cancer care: a prospective randomized crossover pilot studyDifferential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids.Classification of pain in cancer patients--a systematic literature review.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessment.Pharmacological options for the management of refractory cancer pain-what is the evidence?Morphine for chronic neuropathic pain in adults.Opioids for cancer pain - an overview of Cochrane reviews.Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain.Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine.A retrospective study of the association between haematological and biochemical parameters and morphine intolerance in patients with cancer pain.Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain.Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain.CYP2D6 phenotype-specific codeine population pharmacokinetics.
P2860
Q24185873-477A97FC-8675-45DE-B038-E31C142BF939Q24201079-3E82B7D5-C1B1-401E-B6A4-5A0A7DC77983Q24243158-80B5D3B6-4FAC-4AF4-BA16-7B09190EB64FQ28353103-4D2590C3-C0A0-4CB1-A27C-0D9215ADE0FFQ33727191-FD4B8743-4B40-4E18-B2E8-466A91D1C8ACQ34224925-05F73022-1860-4A39-9478-C992105779B5Q35391296-8F282E6E-8E52-45DA-9175-83B4EAF7A0E7Q35827481-33034D3E-7F8D-430F-AAE6-E3D373F30CFEQ37415051-6092D69B-7723-48B8-A933-512E528C1E1FQ37895002-3CBE001B-6CDB-4610-A84F-2B2A3E79EAD1Q38178739-1F78AF05-AB67-419A-8DBC-C41A2B9ABEEFQ38370071-B71006F3-A0D3-42E1-B0D6-5AC4E4E2594AQ38771530-DDFC268D-C55D-4656-A282-BE734B88EA6AQ39153206-0E912829-CB58-4AC5-A60E-9AE814612C38Q39395812-E14D6399-3CEC-4CDE-AF1A-C71CFF4F1A4AQ43243208-FA9B7FCC-D408-4C3A-A1EE-5A68C79F8726Q43968416-A28AB9C6-7E08-4949-8FF2-4501FAFDBDC7Q44775521-0B9DAFF4-978D-4B49-959C-8F5E5BA57D25Q44862502-AA402996-BFD0-44B7-AC02-79153C1D4C34Q46122578-177649E4-B266-4A94-9D17-849F1AD46A21Q53644957-EBCE371B-0905-46DD-BE2C-76812B02563A
P2860
Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
@en
type
label
Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
@en
prefLabel
Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.
@en
P2093
P1476
Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain
@en
P2093
P304
P356
10.1016/0885-3924(95)00148-4
P50
P577
1996-02-01T00:00:00Z